[Methylenetetrahydrofolate reductase [correction of reducatase] polymorphism and asthma]

Zhonghua Jie He He Hu Xi Za Zhi. 2003 Mar;26(3):161-4.
[Article in Chinese]

Abstract

Objective: To evaluate the association between the methylenetetrahydrofolate reductase C/T polymorphism and the prevalence and course of asthma.

Method: Genotypes were determined in 433 asthmatic patients and 1 249 healthy subjects by the polymerase chain reaction and restriction fragment length polymorphism method.

Results: The frequencies of the three genotypes were 40.27% for CC, 48.44% for CT, 11.29% for TT and the frequency of allelic T was 35.51% in controls. The frequency of TT genotype in atopic asthmatic patients was significantly higher than that in controls (P = 0.026). The OR for the TT genotype compared with all CC and CT genotypes was 1.61 (95% CI 1.06 approximately 2.47).

Conclusion: These results imply that homozygosity for this common mutation significantly increases the risk of atopic asthma.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Asthma / enzymology
  • Asthma / genetics*
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Point Mutation
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length*

Substances

  • Methylenetetrahydrofolate Reductase (NADPH2)